Successful Treatment of Hepatitis C in Renal Transplant Recipient. A Case Report from Pakistan

Shobha Luxmi; Rehan Nasir Khan; Muhammad Tassaduq Khan; Rashid Bin Hamid

Successful Treatment of Hepatitis C in Renal Transplant Recipient. A Case Report from Pakistan

Authors

Shobha Luxmi National Institute of Solid Organ & Tissue Transplant, Dow University of Health Sciences, Karachi Pakistan
Rehan Nasir Khan National Institute of Solid Organ & Tissue Transplant, Dow University of Health Sciences, Karachi Pakistan
Muhammad Tassaduq Khan National Institute of Solid Organ & Tissue Transplant, Dow University of Health Sciences, Karachi Pakistan
Rashid Bin Hamid National Institute of Solid Organ & Tissue Transplant, Dow University of Health Sciences, Karachi Pakistan

Abstract

The treatment of hepatitis C is a therapeutic challenge in renal transplant recipients. Interferon based regimens are relatively
contraindicated due to their side effects and high risk of graft failure. With the availability of direct antivirals the situation has changed now and sustained virological response (SVR)>90% had been achieved in patients with normal kidney function. There is limited data available on the safety of these agents in renal transplant recipients. Here we report a case of a kidney transplant recipient with Hepatitis C genotype 3 infections successfully treated with Sofosbuvir and Daclatasvir based regimen. This is the first reported case from Pakistan.

Downloads

Published

09-09-2022

How to Cite

Luxmi, S., Khan, R. N., Khan, M. T., & Hamid, R. B. (2022). Successful Treatment of Hepatitis C in Renal Transplant Recipient. A Case Report from Pakistan. Infectious Diseases Journal of Pakistan, 27(4), 98–99. Retrieved from https://ojs.idj.org.pk/index.php/Files/article/view/65